Fundz

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

PUBLIC · SCNIFeb 13, 2024

Company

Scinai Immunotherapeutics Ltd

JerusalemManufacturingBiotechnologyPharmaceuticalBiopharma

Description

Scinai Immunotherapeutics announces the appointment of Liat Halpert as Head of Business Development and Sales.

Quick answer

Scinai Welcomes Liat Halpert as Head of Business Development and Sales (February 13, 2024). Scinai Immunotherapeutics Ltd is based in Jerusalem, Jerusalem District, Israel.

What did Scinai Immunotherapeutics Ltd announce on February 13, 2024?
Scinai Immunotherapeutics announces the appointment of Liat Halpert as Head of Business Development and Sales.
What does Scinai Immunotherapeutics Ltd do?
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the...
Where is Scinai Immunotherapeutics Ltd based?
Scinai Immunotherapeutics Ltd is based in Jerusalem, Jerusalem District, Israel.
Which similar companies made leadership changes around the same time?
YS Biopharma (February 14, 2024), AbbVie Inc. (February 20, 2024), Jazz Pharmaceuticals plc (February 21, 2024) and Everest Medicines (March 18, 2024) also announced leadership changes within 45 days of Scinai Immunotherapeutics Ltd.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Scinai Immunotherapeutics Ltd, and when

A new leader at Scinai Immunotherapeutics Ltd brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Scinai Immunotherapeutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scinai Immunotherapeutics Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Scinai Immunotherapeutics Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scinai Immunotherapeutics Ltd

Location

JERUSALEM BIOPARK, 2ND FLOOR,

Jerusalem, Jerusalem District, Israel

About

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scinai Immunotherapeutics Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Amir
Likely contact at this company
••••••••@••••••••

See Amir's verified email →

Solomon
Senior decision-maker at this company
••••••••@••••••••

See Solomon's verified email →

Gal
Senior decision-maker at this company
••••••••@••••••••

See Gal's verified email →

Shirly
Likely contact at this company
••••••••@••••••••

See Shirly's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Scinai Immunotherapeutics Ltd's next move

Learn about Strategic plan

Scinai Immunotherapeutics Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.